Medication  ||| S:0 E:11 ||| NNP
and  ||| S:11 E:15 ||| CC
breastfeeding  ||| S:15 E:29 ||| VBD
It  ||| S:29 E:32 ||| PRP
is  ||| S:32 E:35 ||| VBZ
well  ||| S:35 E:40 ||| RB
accepted  ||| S:40 E:49 ||| VBN
that  ||| S:49 E:54 ||| IN
the  ||| S:54 E:58 ||| DT
best  ||| S:58 E:63 ||| JJS
feeding  ||| S:63 E:71 ||| NN
method  ||| S:71 E:78 ||| NN
for  ||| S:78 E:82 ||| IN
infants  ||| S:82 E:90 ||| NN
is  ||| S:90 E:93 ||| VBZ
breastfeeding ||| S:93 E:106 ||| VBN
,  ||| S:106 E:108 ||| ,
due  ||| S:108 E:112 ||| JJ
to  ||| S:112 E:115 ||| TO
its  ||| S:115 E:119 ||| PRP$
numerous  ||| S:119 E:128 ||| JJ
biological  ||| S:128 E:139 ||| NN
and  ||| S:139 E:143 ||| CC
clinical  ||| S:143 E:152 ||| JJ
effects  ||| S:152 E:160 ||| NNS
on  ||| S:160 E:163 ||| IN
child  ||| S:163 E:169 ||| NN
and  ||| S:169 E:173 ||| CC
maternal  ||| S:173 E:182 ||| JJ
health ||| S:182 E:188 ||| NN
.  ||| S:188 E:190 ||| .
The  ||| S:190 E:194 ||| DT
use  ||| S:194 E:198 ||| NN
of  ||| S:198 E:201 ||| IN
medication  ||| S:201 E:212 ||| NN
by  ||| S:212 E:215 ||| IN
the  ||| S:215 E:219 ||| DT
nursing  ||| S:219 E:227 ||| NN
mother  ||| S:227 E:234 ||| NN
and  ||| S:234 E:238 ||| CC
the  ||| S:238 E:242 ||| DT
physician ||| S:242 E:251 ||| NN
's  ||| S:251 E:254 ||| POS
advice  ||| S:254 E:261 ||| NN
to  ||| S:261 E:264 ||| TO
stop  ||| S:264 E:269 ||| VB
nursing  ||| S:269 E:277 ||| NNS
are  ||| S:277 E:281 ||| VBP
the  ||| S:281 E:285 ||| DT
most  ||| S:285 E:290 ||| RBS
common  ||| S:290 E:297 ||| JJ
reasons  ||| S:297 E:305 ||| NNS
for  ||| S:305 E:309 ||| IN
the  ||| S:309 E:313 ||| DT
cessation  ||| S:313 E:323 ||| NN
of  ||| S:323 E:326 ||| IN
breastfeeding ||| S:326 E:339 ||| NN
.  ||| S:339 E:341 ||| .
The  ||| S:341 E:345 ||| DT
physician  ||| S:345 E:355 ||| NN
plays  ||| S:355 E:361 ||| VBZ
an  ||| S:361 E:364 ||| DT
extremely  ||| S:364 E:374 ||| RB
delicate  ||| S:374 E:383 ||| JJ
role  ||| S:383 E:388 ||| NN
and  ||| S:388 E:392 ||| CC
should  ||| S:392 E:399 ||| MD
be  ||| S:399 E:402 ||| VB
able  ||| S:402 E:407 ||| JJ
to  ||| S:407 E:410 ||| TO
assess  ||| S:410 E:417 ||| VB
risks  ||| S:417 E:423 ||| NNS
and  ||| S:423 E:427 ||| CC
benefits  ||| S:427 E:436 ||| NNS
for  ||| S:436 E:440 ||| IN
both  ||| S:440 E:445 ||| DT
mother  ||| S:445 E:452 ||| NN
and  ||| S:452 E:456 ||| CC
child ||| S:456 E:461 ||| NN
.  ||| S:461 E:463 ||| .
The  ||| S:463 E:467 ||| DT
main  ||| S:467 E:472 ||| JJ
factors  ||| S:472 E:480 ||| NNS
that  ||| S:480 E:485 ||| WDT
must  ||| S:485 E:490 ||| MD
be  ||| S:490 E:493 ||| VB
taken  ||| S:493 E:499 ||| VBN
into  ||| S:499 E:504 ||| IN
account  ||| S:504 E:512 ||| NN
include  ||| S:512 E:520 ||| VBP
pharmacokinetics ||| S:520 E:536 ||| VBN
,  ||| S:536 E:538 ||| ,
the  ||| S:538 E:542 ||| DT
duration  ||| S:542 E:551 ||| NN
of  ||| S:551 E:554 ||| IN
maternal  ||| S:554 E:563 ||| JJ
therapy ||| S:563 E:570 ||| NN
,  ||| S:570 E:572 ||| ,
the  ||| S:572 E:576 ||| DT
age  ||| S:576 E:580 ||| NN
of  ||| S:580 E:583 ||| IN
the  ||| S:583 E:587 ||| DT
infant  ||| S:587 E:594 ||| NN
and  ||| S:594 E:598 ||| CC
the  ||| S:598 E:602 ||| DT
general  ||| S:602 E:610 ||| JJ
health  ||| S:610 E:617 ||| NN
of  ||| S:617 E:620 ||| IN
the  ||| S:620 E:624 ||| DT
infant ||| S:624 E:630 ||| NN
.  ||| S:630 E:632 ||| .
All  ||| S:632 E:636 ||| DT
physicians  ||| S:636 E:647 ||| NNS
should  ||| S:647 E:654 ||| MD
have  ||| S:654 E:659 ||| VB
access  ||| S:659 E:666 ||| NN
to  ||| S:666 E:669 ||| TO
reliable  ||| S:669 E:678 ||| JJ
and  ||| S:678 E:682 ||| CC
updated  ||| S:682 E:690 ||| JJ
information  ||| S:690 E:702 ||| NN
on  ||| S:702 E:705 ||| IN
medication  ||| S:705 E:716 ||| NN
safety  ||| S:716 E:723 ||| NN
during  ||| S:723 E:730 ||| IN
breastfeeding  ||| S:730 E:744 ||| NNS
( ||| S:744 E:745 ||| -LRB-
reference  ||| S:745 E:755 ||| NN
books ||| S:755 E:760 ||| NNS
,  ||| S:760 E:762 ||| ,
online  ||| S:762 E:769 ||| JJ
medical  ||| S:769 E:777 ||| JJ
literature ||| S:777 E:787 ||| NN
) ||| S:787 E:788 ||| -RRB-
.  ||| S:788 E:790 ||| .
Few  ||| S:790 E:794 ||| JJ
drugs  ||| S:794 E:800 ||| NNS
have  ||| S:800 E:805 ||| VBP
been  ||| S:805 E:810 ||| VBN
demonstrated  ||| S:810 E:823 ||| VBN
to  ||| S:823 E:826 ||| TO
be  ||| S:826 E:829 ||| VB
absolutely  ||| S:829 E:840 ||| RB
contraindicated  ||| S:840 E:856 ||| VBN
during  ||| S:856 E:863 ||| IN
breastfeeding ||| S:863 E:876 ||| NN
.  ||| S:876 E:878 ||| .
Nevertheless  ||| S:878 E:891 ||| RB
clear ||| S:891 E:896 ||| JJ
,  ||| S:896 E:898 ||| ,
safe  ||| S:898 E:903 ||| JJ
and  ||| S:903 E:907 ||| CC
reliable  ||| S:907 E:916 ||| JJ
information  ||| S:916 E:928 ||| NN
is  ||| S:928 E:931 ||| VBZ
still  ||| S:931 E:937 ||| RB
lacking  ||| S:937 E:945 ||| VBG
for  ||| S:945 E:949 ||| IN
most  ||| S:949 E:954 ||| JJS
drugs  ||| S:954 E:960 ||| NNS
and  ||| S:960 E:964 ||| CC
it  ||| S:964 E:967 ||| PRP
would  ||| S:967 E:973 ||| MD
be  ||| S:973 E:976 ||| VB
desirable  ||| S:976 E:986 ||| JJ
to  ||| S:986 E:989 ||| TO
improve  ||| S:989 E:997 ||| VB
the  ||| S:997 E:1001 ||| DT
knowledge  ||| S:1001 E:1011 ||| NN
about  ||| S:1011 E:1017 ||| IN
mechanisms  ||| S:1017 E:1028 ||| NNS
and  ||| S:1028 E:1032 ||| CC
consequences  ||| S:1032 E:1045 ||| NNS
of  ||| S:1045 E:1048 ||| IN
infant  ||| S:1048 E:1055 ||| JJ
exposure  ||| S:1055 E:1064 ||| NN
to  ||| S:1064 E:1067 ||| TO
drug  ||| S:1067 E:1072 ||| NN
present  ||| S:1072 E:1080 ||| NN
in  ||| S:1080 E:1083 ||| IN
milk ||| S:1083 E:1087 ||| NN
.  ||| S:1087 E:1089 ||| .
